secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vistagen Therapeutics, Inc. (VTGN)
CIK:        0001411685
Form:       8-K
Filed at:   2026-02-20T23:59:59+00:00
Accession:  0001628280-26-010035
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Vistagen Therapeutics director Paul Edick resigns; board vacancy to be filled
-----------------------------------------------------------------------------

- Paul Edick resigned from the Board of Directors effective February 13, 2026.
- The Company is actively seeking new candidates to fill the resulting vacancy.
- No reason for resignation was disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411685/000162828026010035/0001628280-26-010035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411685/000162828026010035/vtgn-20260213.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-010035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer